Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Personal Side of COVID-19: Q&A with Philip A. Waller, MD

Susan Bernstein  |  April 3, 2020

The main concern we are dealing with is that patients who are on Plaquenil (hydroxychloroquine) are concerned they will not be able to get their medicine because the drug is being used in the treatment of COVID-19.

Q: How is the pandemic affecting you and your staff personally?
I seem to be the most anxious person in the office. New York frightened me. I am doing my best to reassure staff and patients, which is difficult because I’m a negative person in daily life.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

My staff has been wonderful through everything so far. That may change as more people get the virus and die, but they are making patients as comfortable as they can. They have really stepped up. We, of course, are checking temperatures, asking medical questions, etc. every day on every staff member.

My biggest concern is that insurance companies will not pay the amount for telemedicine visits as promised. If the payments are delayed or paid incorrectly, we will need to lay off employees.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With everything in the world being so fluid on a daily basis, everything [I’ve said here] could change completely tomorrow. [Our staff members] are doing everything they can do to deliver quality medical care to all of our patients, and hoping we all stay healthy and get through this.


Susan Bernstein is a freelance journalist based in Atlanta.

Page: 1 2 | Single Page
Share: 

Filed under:Uncategorized Tagged with:CareercoronavirusCOVID-19Practice Managementrheumatologists

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

    July 14, 2020

    The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences